- PIM Kinase as an Executional Target in Cancer
-
Zhang X, Song M, Kundu JK, Lee MH, Liu ZZ
- KMID: 2425313
- J Cancer Prev.
- 2018 Sep;23(3):109-116.
- doi: 10.15430/JCP.2018.23.3.109
PIM (proviral integration site for moloney murine leukemia virus) kinase plays a key role as an oncogene in various cancers including myeloma, leukemia, prostate and breast cancers. The aberrant expression... -
- CITED
-
- Close
- SHARE
-
- Close
- Resveratrol Inhibits IL-6-Induced Transcriptional Activity of AR and STAT3 in Human Prostate Cancer LNCaP-FGC Cells
-
Lee MH, Kundu JK, Keum YS, Cho YY, Surh YJ, Choi BY
- KMID: 2380320
- Biomol Ther.
- 2014 Sep;22(5):426-430.
- doi: 10.4062/biomolther.2014.061
Prostate cancer is the most frequently diagnosed cancer. Although prostate tumors respond to androgen ablation therapy at an early stage, they often acquire the potential of androgen-independent growth. Elevated transcriptional... -
- CITED
-
- Close
- SHARE
-
- Close
- Inhibition of Phorbol Ester-induced Mouse Skin Tumor Promotion and COX-2 Expression by Celecoxib: C/EBP as a Potential Molecular Target
-
Chun KS, Kundu JK, Park KK, Chung WY, Surh YJ
- KMID: 2166060
- Cancer Res Treat.
- 2006 Jun;38(3):152-158.
PURPOSE: Inflammation acts as a driving force for the development of cancer. Multiple lines of evidence suggest that nonsteroidal anti-inflammatory drugs, especially those that specifically target cyclooxygenase-2 (COX-2), are effective... -
- CITED
-
- Close
- SHARE
-
- Close
